ViewRay, Inc. (NASDAQ:VRAY) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining the ViewRay First Quarter Earnings Call. My name is Kate, and I will be the moderator for today's call.
Viewray Inc. (VRAY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hudson Executive Capital Douglas Braunstein And James Woolery | 15,752,093 | $54,502,242 | 6.49% | |
| 2. | Pura Vida Investments Efrem Kamen | 9,213,231 | $31,877,779 | -27% | 3.34% |
| 3. | Pura Vida Investments Efrem Kamen | 6,699,600 | $23,180,616 | 2.43% | |
| 4. | SilverArc Capital Devesh Gandhi | 2,793,748 | $9,666,368 | +17% | 3.99% |
| 5. | Kahn Brothers Irving Kahn | 1,620,797 | $5,608,000 | -1% | 0.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.68 | 200 | Director | 192,790 | 2022-11-28 | Filing | |
| $4.70 | 100 | Director | 192,590 | 2022-11-28 | Filing | |
| $4.68 | 8,638 | Director | 192,490 | 2022-11-28 | Filing | |
| $4.70 | 2,531 | Director | 183,852 | 2022-11-28 | Filing | |
| $4.69 | 1,665 | Director | 181,321 | 2022-11-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.13 | 42,000 | Officer | 654,368 | 2023-03-03 | Filing | |
| $7.02 | 4,000,000 | Large Shareholder | 11,108,222 | 2021-11-08 | Filing | |
| $7.02 | 4,000,000 | Large Shareholder | 11,108,222 | 2021-11-08 | Filing | |
| $5.97 | 4,300,000 | Large Shareholder | 15,108,222 | 2021-06-08 | Filing | |
| $5.97 | 4,300,000 | Large Shareholder | 15,108,222 | 2021-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 15,484,750 | $53,577,235 | 0.08% | |
| 2. | 11,991,117 | $41,489,265 | 3.9% | |
| 3. | 10,646,741 | $36,837,725 | 0% | |
| 4. | 10,332,863 | $35,751,708 | 0.03% | |
| 5. | 10,226,258 | $35,382,853 | 0% |
News See All
Do You Believe in the Growth Prospects of ViewRay (VRAY)?
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
ViewRay, Inc. (NASDAQ:VRAY) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. And welcome to the ViewRay Q4 2022 Earnings Call. At this time, all lines are in a listen-only mode.
Top 5 Stock Picks of Efrem Kamen's Pura Vida Investments
In this article, we shall discuss the top 5 stock picks of Efrem Kamen's Pura Vida Investments.
5 Cheap Growth Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 5 cheap growth stocks to buy according to billionaire Steve Cohen.
5 Pharmaceutical Stocks to Buy According to Efrem Kamen's Pura Vida Investments
Below is the list of 5 pharmaceutical stocks to buy according to Efrem Kamen's Pura Vida Investments hedge fund.
Hedge Funds Are Warming Up To ViewRay, Inc. (VRAY)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is VRAY A Good Stock To Buy Now?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Were Hedge Funds Right About Dumping ViewRay, Inc. (VRAY)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
